ALYSON HANDY: Open Payments
NPI 1982634598 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,455 in 134 payments from 21 companies in 2025. Trend: 2023 $1,644 · 2024 $2,266 · 2025 $2,455
Food & beverage: $2,445Education: $10
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $477 |
| Janssen Biotech, Inc. | 21 | $415 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $302 |
| Phathom Pharmaceuticals, Inc. | 20 | $223 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 18 | $198 |
| Ardelyx, Inc. | 7 | $165 |
| Regeneron Healthcare Solutions, Inc. | 4 | $119 |
| Lilly USA, LLC | 5 | $81 |
| Madrigal Pharmaceuticals | 2 | $69 |
| Exact Sciences Corporation | 2 | $58 |
Products named: TREMFYA, VOQUEZNA, XIFAXAN, ENTYVIO, LINZESS, DUPIXENT, IBSRELA, RINVOQ.
Industry payments across NY — which companies pay providers there.
